Indication
Bretaris Genuair is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Loading your page…
Loading your page…
Pulmonary Disease, Chronic Obstructive
Marketing Authorisation Holder: Covis Pharma Europe B.V.
EMA Authorisation: 20/07/2012
INN: aclidinium bromide
AI Drug & Interaction Analysis
Free account required
Ask Osler about Bretaris Genuair: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.